Have a personal or library account? Click to login

Transfusion of rare cryopreserved red blood cell units stored at –80°C: the French experience

Paid access
|Mar 2020

References

  1. Smith AU. Prevention of haemolyis during freezing and thawing of red blood cells. Lancet 1950;2:910–11.10.1016/S0140-6736(50)91861-7
  2. Chaplin H, Mollison PL. Improved storage of red cells at -20°C. Lancet 1953;1:215–18.10.1016/S0140-6736(53)90887-3
  3. Peyrard T, Pham BN, Le Pennec PY, Rouger P. The rare blood groups: a public health challenge. Transf Clin Biol 2008;15:109–19.10.1016/j.tracli.2008.02.001
  4. Moullec J. The national index of rare type donors. Transfusion (Paris) 1966;9:163–6.10.1016/S0372-1248(66)80054-1
  5. Salmon C, Rouger P. Un problème national: la banque d’unités de globules rouges congelés de groupes rares. Rev Fr Transfus Immunohematol 1980;23:219–22.
  6. Fialaire-Legendre A, Fourcelot S, Duffy V, et al. Cryopréservation des concentrés de globules rouges (CGR) en système clos (SC) et ouvert (SO): bilan de deux années d’expérience à l’unité de cryobiologie d’Henri Mondor. Transf Clin Biol 2005;12(Suppl 1):S85.10.1016/S1246-7820(05)80637-8
  7. Peyrard T, Fialaire-Legendre A, Noizat-Pirenne F, Bierling P, Rouger P, Le Pennec PY. A national file of individuals presenting a rare blood phenotype and a national blood bank for rare blood units: a five-year experience (abstract). Transfusion 2006;46(Suppl):132A.
  8. Meryman HT. Frozen red cells. Transf Med Rev 1989;3:121–7.10.1016/S0887-7963(89)70073-0
  9. Umlas J, Jacobson M, Kevy SV. Suitable survival and half-life of red cells after frozen storage in excess of 10 years. Transfusion 1991;31:648–9.10.1046/j.1537-2995.1991.31791368344.x1891794
  10. Moore GL. Long-term storage and preservation of red blood cells. Biotechnology 1991:19:31–46.10.1016/B978-0-7506-9120-8.50007-X1786474
  11. Valeri CR, Ragno G, Pivacek LE, et al. An experiment with glycerol-frozen red blood cells stored at -8o°C for up to 37 years. Vox Sang 2000;79:168–74.10.1046/j.1423-0410.2000.7930168.x
  12. Lelkens CCM, Noorman F, Koning JG, et al. Stability after thawing of RBCs frozen with the high- and low-glycerol method. Transfusion 2003;43:157–64.10.1046/j.1537-2995.2003.00293.x12559010
  13. Valeri CR, Srey R, Tilahun D, Ragno G. The in vitro quality of red blood cells frozen with 40 percent (wt/vol) glycerol at -80°C for 14 years, deglycerolized with the Haemonetics ACP 215 and stored at 4°C in additive solution-1 or additive solution-3 for up to 3 weeks. Transfusion 2004;44:990–5.10.1111/j.1537-2995.2004.04001.x15225238
  14. Lecak J, Scott K, Young C, Hannon J, Acker JP. Evaluation of red blood cells stored at -80°C in excess of 10 years. Transfusion 2004;44:1306–13.10.1111/j.1537-2995.2004.03271.x15318853
  15. Hess JR. Red cell freezing and its impact on the supply chain. Transf Med 2004;14:1–8.10.1111/j.0958-7578.2004.00472.x15043586
  16. Scott KL, Lecak J, Acker JP. Biopreservation of red blood cells: past, present and future. Transf Med Rev 2005;19:127–42.10.1016/j.tmrv.2004.11.00415852241
  17. Anstee D, Levene C, Mallory D, et al. Rare blood. Vox Sang 1999;77:58–62.10.1046/j.1423-0410.1999.7710058.x
  18. Smart E. South African rare donor panel. Vox Sang 2006;1:210–12.10.1111/j.1751-2824.2006.00032.x
  19. Guide to the preparation, use and quality assurance of blood components. 13th ed. Council of Europe Publishing, Strasbourg, France;2007:154.
  20. Technical manual. 16th ed. Bethesda: American Association of Blood Banks, 2008:210–11.
  21. Reesink HW, Engelfriet CP, Schennach H, et al. Donors with a rare pheno (geno) type. Vox Sang 2008;95:236–53.10.1111/j.1423-0410.2008.01084.x19121189
  22. Andreu G, Morel P, Forestier F, et al. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002;42:1249–52.10.1046/j.1537-2995.2002.00202.x12423521
  23. Décret n°94-68 du 24 janvier 1994 relatif aux règles d’hémovigilance pris pour l’application de l’article L.666-12 du Code de la santé publique et modifiant ce code. Journal Officiel de la République Française 1994;1346-50.
  24. Décision du 5 janvier 2007 fixant la norme, le contenu et les modalités de transmission de la fiche de déclaration d’effet indésirable survenu chez un receveur de produit sanguin labile. Journal Officiel de la République Française 2007;texte 24/162.
  25. Woodfield G, Poole J, Nance ST, Daniels G. A review of the ISBT rare blood donor program. Immunohematology 2004;20:244–8.10.21307/immunohematology-2019-457
DOI: https://doi.org/10.21307/immunohematology-2019-224 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 13 - 17
Published on: Mar 16, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 T. Peyrard, B.N. Pham, P.Y. Le Pennec, P. Rouger, published by American National Red Cross
This work is licensed under the Creative Commons License.